The Association Between Methionine Synthase A2756G Polymorphism and Hematological Cancer: A Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Jan 10

PMID 29310321

Citations 2

Authors

Bing Wu

Kang Liu

Jun-Ping Yang

Yan Hu

Jun Zhang

Jun-Xiang He

Affiliations

Soon will be listed here.

Abstract

Background: Numerous studies have focused on the association of methionine synthase (MS) A2756G polymorphism and acute hematological cancer risk. However, the results remain inconsistent. Therefore, a meta-analysis was performed to derive a more precise estimate of the association between them.

Methods: This meta-analysis involved 25 articles (26 studies) including 8641 hematological cancer patients and 15,498 controls. The pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) of the association between MS A2756G polymorphism and the risk of hematological cancer were calculated.

Results: Overall, no significant increased risks were found between MS A2756G polymorphism and hematological cancer risk under allelic homozygote (GA vs AA: OR = 0.98, 95% CI = 0.89-1.07, P = .62), heterozygote (GG vs AA: OR = 0.99, 95% CI = 0.85-1.15, P = .91), dominant (AG+GG vs AA: OR = 0.99, 95% CI = 0.90-1.08, P = .93), and recessive (GG vs AG+AA: OR = 1.00, 95% CI = 0.86-1.16, P = .97) models, respectively. In the stratified analyses by ethnicity and source of controls, there were still no significant associations between them in all genetic models.

Conclusions: Therefore, these findings demonstrate that MS A2756G polymorphism may not be a risk factor for hematological cancer.

Citing Articles

Linking homocysteine and ferroptosis in cardiovascular disease: insights and implications.

Li X, Zhou Z, Tao Y, He L, Zhan F, Li J Apoptosis. 2024; 29(11-12):1944-1958.

PMID: 39044092 DOI: 10.1007/s10495-024-01999-6.

Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke.

Poddar R Exp Neurol. 2020; 336:113541.

PMID: 33278453 PMC: 7856041. DOI: 10.1016/j.expneurol.2020.113541.

References

Thakkinstian A, McElduff P, DEste C, Duffy D, Attia J . A method for meta-analysis of molecular association studies. Stat Med. 2004; 24(9):1291-306. DOI: 10.1002/sim.2010. View

How C, Hui A, Alajez N, Shi W, Boutros P, Clarke B . MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PLoS One. 2013; 8(7):e67846. PMC: 3701631. DOI: 10.1371/journal.pone.0067846. View

Wilson A, Leclerc D, Saberi F, Campeau E, Hwang H, Shane B . Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency. Am J Hum Genet. 1998; 63(2):409-14. PMC: 1377317. DOI: 10.1086/301976. View

Kim H, Lee I, Kim Y, Tran H, Yang D, Lee J . Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol. 2007; 140(3):287-94. DOI: 10.1111/j.1365-2141.2007.06893.x. View

Novotna B, Topinka J, Solansky I, Chvatalova I, Lnenickova Z, Sram R . Impact of air pollution and genotype variability on DNA damage in Prague policemen. Toxicol Lett. 2007; 172(1-2):37-47. DOI: 10.1016/j.toxlet.2007.05.013. View

Lee K, Lan Q, Kricker A, Purdue M, Grulich A, Vajdic C . One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet. 2007; 122(5):525-33. DOI: 10.1007/s00439-007-0431-2. View

Schiffman J . Applying molecular epidemiology in pediatric leukemia. J Investig Med. 2015; 64(2):355-60. DOI: 10.1097/JIM.0000000000000204. View

Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H . Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood. 2001; 97(10):3205-9. DOI: 10.1182/blood.v97.10.3205. View

Segel G, Lichtman M . Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells Mol Dis. 2004; 32(1):246-61. DOI: 10.1016/j.bcmd.2003.10.005. View

10.

Gast A, Bermejo J, Flohr T, Stanulla M, Burwinkel B, Schrappe M . Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. Leukemia. 2006; 21(2):320-5. DOI: 10.1038/sj.leu.2404474. View

11.

Lincz L, Scorgie F, Kerridge I, Potts R, Spencer A, Enno A . Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol. 2003; 120(6):1051-4. DOI: 10.1046/j.1365-2141.2003.04220.x. View

12.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

13.

Chiu B, Weisenburger D, Hoar Zahm S, Cantor K, Gapstur S, Holmes F . Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2004; 13(4):525-31. View

14.

Soeken K, Sripusanapan A . Assessing publication bias in meta-analysis. Nurs Res. 2003; 52(1):57-60. DOI: 10.1097/00006199-200301000-00009. View

15.

Campbell V, Copland M . Hedgehog signaling in cancer stem cells: a focus on hematological cancers. Stem Cells Cloning. 2015; 8:27-38. PMC: 4325629. DOI: 10.2147/SCCAA.S58613. View

16.

Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H, Moons K . More than numbers: the power of graphs in meta-analysis. Am J Epidemiol. 2008; 169(2):249-55. DOI: 10.1093/aje/kwn340. View

17.

Weiner A, Beresina O, Voronina E, Voropaeva E, Boyarskih U, Pospelova T . Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. Leuk Res. 2010; 35(4):508-15. DOI: 10.1016/j.leukres.2010.10.004. View

18.

Lima C, Ortega M, Ozelo M, Araujo R, De Souza C, Lorand-Metze I . Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res. 2007; 32(3):401-5. DOI: 10.1016/j.leukres.2007.06.001. View

19.

Milne E, Greenop K, Scott R, Haber M, Norris M, Attia J . Folate pathway gene polymorphisms, maternal folic acid use, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2014; 24(1):48-56. DOI: 10.1158/1055-9965.EPI-14-0680. View

20.

Ruiz-Cosano J, Torres-Moreno D, Conesa-Zamora P . Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population. J BUON. 2013; 18(2):486-90. View